ibutilide
Showing 1 - 6 of 6
Long QT Syndrome, Abnormalities, Drug-Induced Trial in Indianapolis (Progesterone, Ibutilide)
Recruiting
- Long QT Syndrome
- Abnormalities, Drug-Induced
- Progesterone
- Ibutilide
-
Indianapolis, IndianaIndiana University
Aug 3, 2022
Long QT Syndrome, Abnormalities, Drug-Induced Trial in Indianapolis (Progesterone, Ibutilide, Testosterone)
Recruiting
- Long QT Syndrome
- Abnormalities, Drug-Induced
- Progesterone
- +3 more
-
Indianapolis, Indiana
- +2 more
Aug 3, 2022
Atrial Fibrillation, Persistent Atrial Fibrillation Trial in New York (device, procedure, drug)
Terminated
- Atrial Fibrillation
- Persistent Atrial Fibrillation
- CardioInsight ECGI Mapping System
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jan 28, 2020
Long QT Syndrome Trial in Indianapolis (Testosterone, Progesterone, Placebo)
Completed
- Long QT Syndrome
- Testosterone
- +3 more
-
Indianapolis, IndianaIndiana University
Aug 15, 2019
Persistent Atrial Fibrillation Trial in Canada, Korea, Republic of, United States (Ibutilide, Placebo)
Completed
- Persistent Atrial Fibrillation
- Ibutilide
- Placebo
-
Sacramento, California
- +6 more
Jan 17, 2018
Prolonged QT Interval in EKG and Sudden Death Trial in Indianapolis (Progesterone, Placebo, Ibutilide)
Completed
- Prolonged QT Interval in EKG and Sudden Death
- Progesterone
- +2 more
-
Indianapolis, Indiana
- +1 more
Oct 29, 2015